Hearing Impairment Clinical Trial
Official title:
The EarLens System Long Term Safety and Efficacy Definitive Multi-Center Study
Verified date | January 2016 |
Source | EarLens Corporation |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Food and Drug Administration |
Study type | Interventional |
The EarLens System is an assistive hearing device that is intended to provide amplification for the treatment of patients with sensorineural hearing impairment. The purpose of this multi-center definitive study is to assess the safety and efficacy of the EarLens System for subjects with bilateral mild to severe sensorineural hearing impairments wearing the fully activated system in their daily lives for a 4 month period of time. This study is designed to support US and International marketing applications to commercialize the EarLens System. The main efficacy hypothesis is that the EarLens System will be shown to improve speech understanding in quiet.
Status | Completed |
Enrollment | 48 |
Est. completion date | March 2015 |
Est. primary completion date | January 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Age 18 to 85 years - Mild to severe hearing impairment between 125 to 4000 Hz - No significant conductive hearing impairment - Able and willing to commit to travel and time demands of the study Exclusion Criteria: - Must not have known or active medical issues that would preclude having a device including: 1. an abnormal tympanic membrane 2. an abnormal middle ear or history of prior middle ear surgery other than tympanostomy tubes 3. an ear canal anatomy that prevents physicians from seeing adequate amount of the tympanic membrane - Must not have other known or active medical issues including: 1. history of chronic and recurrent ear infections in the past 24 mouths 2. history of dizziness and/or vertigo in the past 24 months 3. taking medications/treatments with known ototoxic effects 4. a rapidly progressive or fluctuating hearing impairment 5. having been diagnosed with having a compromised immune system - Must not fit the definition of a vulnerable subject, as per FDA regulations 21 CFR Parts 50 and 56 - Must not have an ear canal anatomy that preclude manufacture of the device as determined by EarLens manufacturing personnel |
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | University of Iowa Hospitals and Clinics | Iowa City | Iowa |
United States | EarLens Corporation | Menlo Park | California |
United States | Camino Ear Nose and Throat Clinic | San Jose | California |
Lead Sponsor | Collaborator |
---|---|
EarLens Corporation |
United States,
Fay JP, Perkins R, Levy SC, Nilsson M, Puria S. Preliminary evaluation of a light-based contact hearing device for the hearing impaired. Otol Neurotol. 2013 Jul;34(5):912-21. doi: 10.1097/MAO.0b013e31827de4b1. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Determine the Incidence of Serious Device- and Procedure-related Adverse Events. | The analysis of the incidence of serious device- and procedure-related adverse events through the study period. All adverse events will be recorded on case report forms and determinations will be made as to the whether the events are related to the investigational device. | 120 days | Yes |
Primary | Change in Mean Aided Word Recognition Scores (WRS) When Compared to the Baseline Unaided Condition. | Change in mean aided Word Recognition Scores (WRS) when compared to the baseline unaided condition. WRS will be measured using 50-word NU-6 (Northwestern University Auditory Test No.6) recorded materials, presented at 45 dB Hearing Level on a per-ear basis with the test ear isolated for measurement and the results, expressed as a percentage of words correct, averaged across the two ears for each subject. All subject data will then be averaged to obtain the means. The baseline unaided measurements will occur prior to device placement, and the aided condition will be measured at least 30 days post device placement. | Baseline and 30 days | No |
Primary | Audiometric Safety as Shown by no Hearing Change Pre and Post Treatment | The unaided air conduction hearing thresholds will be measured for each individual ear twice before device placement at Visit #1 and averaged to obtain the baseline unaided air conduction hearing thresholds, and the post wear unaided air conduction hearing thresholds will be measured after device removal at Visit #5. A PTA4 (Pure Tone Average at 4 frequencies; 500, 1000, 2000, and 4000 Hz) will be computed both for baseline unaided hearing pre-placement and unaided hearing post-removal for each ear, then averaged across both ears for each subject . A determination of "No Hearing Change" for the subject population will be made if the calculated Hearing Changes of the subject population are 10 dB or less. | Baseline and 120 days | Yes |
Secondary | Functional Gain Over the Frequency Range From 2000 to 10,000 Hz | 10 dB (decibel) change in the averaged pure tone thresholds for the subject population over the frequency range from 2000 to 10,000 Hz (2000, 3000, 4000, 6000, 8000, 9000 and 10,000 Hz). Measurement to be used in analysis are the baseline unaided soundfield thresholds measured prior to device placement and the aided soundfield thresholds measured at least 30 days post placement. Analysis includes calculation of the unaided soundfield thresholds minus aided soundfield thresholds. | Baseline and 30 days | No |
Secondary | Change in Aided HINT 90 Speech Reception Thresholds (SRTs) When Compared to the Baseline Unaided Condition. | Change in aided HINT 90 speech reception thresholds (SRTs) when compared to the baseline unaided condition. SRTs will be measured using HINT materials with the signal (speech level presented from 0 degrees) adapted relative to the noise (presented from 90 degrees held fixed at 60 dB SPL) to determine the signal-to-noise ratio for reporting the whole sentence correct 50% of the time (Nilsson et al., 1994). An improvement in HINT score is indicated as a negative (-) dB value change. A more negative value indicating an improvement of understanding speech and noise. An improvement of -1dB is equivalent to a 10% improvement in understanding speech and noise and is likely of clinical benefit. HINT 90 will be measured twice and averaged to obtain the per subject HINT SRT. All subject data will be averaged to obtain the means. Analysis includes calculation of the unaided measurements (before device placement) minus the aided measurements. | Baseline and 30 days | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04055987 -
Use of Electropalatography to Improve Speech Sound Production
|
N/A | |
Completed |
NCT03687801 -
Clinically Implementing Online Hearing Support Within Hearing Organization
|
N/A | |
Enrolling by invitation |
NCT06051968 -
Effects of an Online Hearing Support for First-time Hearing Aid Users
|
N/A | |
Recruiting |
NCT05083221 -
Effect of an Aural Rehabilitation Program in Hearing-impaired Older Adults
|
N/A | |
Completed |
NCT04794179 -
CROS and Quality of Life of Elderly Cochlear Implant Recipients and Their Care Givers
|
N/A | |
Recruiting |
NCT05003674 -
A Feasibility Study Evaluating the Performance of Focused Multipolar Stimulation in Adult Cochlear Implant Recipients
|
N/A | |
Completed |
NCT01400178 -
Cochlear Implants in Post-lingually Children: Results After 10 Years
|
N/A | |
Completed |
NCT00738244 -
Effectiveness of Hearing-aid Based Wind-noise Algorithm
|
N/A | |
Completed |
NCT03716544 -
Efficacy of Amplification With Hearing Aids for Tinnitus Relief
|
N/A | |
Recruiting |
NCT02779907 -
Prevalence and Associations of Paediatric Chronic Suppurative Otitis Media and Hearing Impairment in Rural Malawi
|
N/A | |
Completed |
NCT02832128 -
Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire)
|
Phase 2 | |
Completed |
NCT01816087 -
Performances of a Brief Assessment Tool for the Early Diagnosis of Geriatric Syndromes by Primary Care Physicians
|
N/A | |
Completed |
NCT00582946 -
Wide-Bandwidth Open Canal Hearing Aid For Better Multitalker Speech Understanding
|
Phase 1 | |
Recruiting |
NCT05847426 -
Improving Early Intervention in Hearing Impaired Children Using Functional Near-Infrared Spectroscopy (fNIRS)
|
N/A | |
Recruiting |
NCT05854719 -
Eyes On Lips? Speechreading Skills and Facial Expression Discrimination in Children With and Without Impaired Hearing
|
N/A | |
Completed |
NCT04469946 -
Hearing Aid Noise Reduction in Pediatric Users Pilot Study (Oticon Pilot Study)
|
N/A | |
Completed |
NCT03575390 -
The Beneficial Effects of Pomegranate on Hearing of Patients Without Hemodialysis
|
N/A | |
Withdrawn |
NCT03966144 -
RoboHearâ„¢ Device: Advanced Haptic Technology That Allows the Deaf to Understand Speech
|
N/A | |
Recruiting |
NCT05805384 -
Evaluating a Noise Reduction Algorithm With Cochlear Implant Users
|
N/A | |
Active, not recruiting |
NCT05815667 -
Effects of the Swedish Internet-based Individualised Active Communication Education (I-ACE) in FTU
|
N/A |